Advanced company searchLink opens in new window

ALLUCENT (UK) LIMITED

Company number 03125708

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
06 Jan 2024 AA Accounts for a medium company made up to 31 December 2022
07 Dec 2023 CS01 Confirmation statement made on 14 November 2023 with updates
07 Dec 2023 PSC05 Change of details for Allucent (Uk) Group Limited as a person with significant control on 17 February 2023
06 Dec 2023 PSC05 Change of details for Allucent (Uk) Group Limited as a person with significant control on 17 February 2023
05 Dec 2023 PSC05 Change of details for Pharm-Olam Group Limited as a person with significant control on 17 February 2023
20 Feb 2023 CERTNM Company name changed pharm-olam international (uk) LIMITED\certificate issued on 20/02/23
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2023-02-17
03 Jan 2023 CS01 Confirmation statement made on 14 November 2022 with no updates
13 Oct 2022 AA Full accounts made up to 31 December 2021
24 Aug 2022 TM01 Termination of appointment of Natalie Kay Gassen as a director on 1 August 2022
13 Jan 2022 AP01 Appointment of Mr Richard William Shimota as a director on 16 December 2021
13 Jan 2022 AP01 Appointment of Mr Mark Alan Goldberg as a director on 16 December 2021
13 Jan 2022 AP01 Appointment of Mr Daniel Agroskin as a director on 16 December 2021
13 Jan 2022 AP01 Appointment of Mr Peter Maurice Strothman as a director on 16 December 2021
13 Jan 2022 TM01 Termination of appointment of Robert James Davie as a director on 16 December 2021
13 Jan 2022 AP03 Appointment of Mr Chris Brennan as a secretary on 16 December 2021
16 Nov 2021 CS01 Confirmation statement made on 14 November 2021 with no updates
12 Nov 2021 AA Full accounts made up to 31 December 2020
09 Aug 2021 PSC02 Notification of Pharm-Olam Group Limited as a person with significant control on 6 April 2016
09 Aug 2021 PSC07 Cessation of Zev Moshe Munk as a person with significant control on 19 June 2020
29 Apr 2021 AA Full accounts made up to 31 December 2019
21 Apr 2021 DISS40 Compulsory strike-off action has been discontinued
20 Apr 2021 CS01 Confirmation statement made on 14 November 2020 with no updates
20 Apr 2021 GAZ1 First Gazette notice for compulsory strike-off
03 Apr 2020 AP01 Appointment of Robert James Davie as a director on 27 March 2020
02 Apr 2020 TM01 Termination of appointment of John David Barry as a director on 27 March 2020